V4 - SARS-CoV-2 & Influenza A/B & RSV, Antigen Combo Test Kit

General information: COVID-19 is an acute respiratory infectious disease. The main manifestations include fever, fatigue and dry cough. Other symptoms might be nasal congestion, runny nose, sore throat, myalgia and diarrhea. Currently, the patients infected by the novel coronavirus are the main source of infection. Asymptomatic infected people can also be an infectious source. Influenza (flu) is a contagious respiratory illness caused by influenza viruses. Influenza viruses can cause mild to severe illness. Some people, such as older people, young children, and people with certain underlying health conditions, are at higher risk for serious flu complications. There are two main types of influenza viruses: types A and B. Both type A and B influenza viruses regularly spread among people, and are responsible for seasonal flu each year. Respiratory syncytial virus (RSV) is the most common virus that causes lower respiratory tract infection in infants and young children. It is mainly transmitted by droplet or direct contact, and the population is generally susceptible. T he peak season is from November to April. Intended use: Fluorecare SARS-CoV-2 & Influenza A/B & RSV Antigen Combined Test Kit is applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2 Antigen), Influenza A virus, Influenza B virus Antigen and/or RSV Antigen in population Oropharyngeal swabs, Nasal swabs and Nasopharyngeal swabs samples. Advantages: Fast results within 15 mins Easy to use - in 3 rapid steps Nasopharyngeal, nasal or oropharyngeal swab All necessary reagents provided (individually packed) High Sensitivity and Specificity P rinciple: The SARS-CoV-2 & Influenza A/B & RSV Antigen is qualitatively detected in population oropharyngeal swabs, nasal swabs or nasopharyngeal swabs samples by the colloidal gold method. After sample added, the SARS-CoV-2 Antigen (or Influenza A/B & RSV) in the sample to be tested is combined with the SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody labelled with colloidal gold on the binding pad to form the SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody-colloidal gold complex. Due to chromatography, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody-colloidal gold complex diffuses along the nitrocellulose’s membrane. Within the detection line area, the SARS-CoV-2 Antigen (or Influenza A/B & RSV)-antibody complex binds to the antibody enclosed within the detection line area, showing a purple-red band. Colloidal gold labelled SARS-CoV-2 Antigen (or Influenza A/B & RSV) antibody diffuses to the quality control line (C) region and is captured by sheep anti-mouse IgG to form red bands. When the reaction is over, the results can be interpreted by visual observation. Components : Test Cassettes (individually packed) Sterile swabs (individually packed) Tube with dropper lid and sample treatment solution (individual) Instruction of use Sensitivity and specificity : Sensitivity: SARS-CoV-2 - 92.9% Influenza A - 91.8% Influenza B - 92.7% RSV - 96.97% Specificity: SARS-CoV-2 - 100% Influenza A - 99.6% Influenza B - 100% RSV - 100% Test Principle: